Orion Oyj
ORNBV · XHEL
Same sector: Health Care.
Orion Oyj-osakeanalyysi →
INVEST INTELLIGENCE
Novo Nordisk A/S ser. B
NOVO-B · XCSE
338,05 DKK
+0,79 % from the previous close
Latest close 2026-07-29.
Not a real-time quote.
Market capitalisation1 503,60 mrd DKK
P/E14,7
52-week range224,25 DKK–450,00 DKK
Reporting currencyDKK
Company in brief
Interesting, but the risks require careful evaluation
The conclusion is based on versioned public source data. This is not a buy or sell recommendation.
Public fundamentals
2025-12-31
Key business figures
Revenue309,06 mrd DKK
Net income102,43 mrd DKK
Free cash flow28,99 mrd DKK
Debt / equity0,67
Source Zapcore Evidence Fusion v1 · collected 2026-07-30 03:08:13.
Analysisis updated
The company was analysed through the unified Intelligence pipeline.
2026-07-30 03:38:39 · NEUTRAL- → Material deterioration in source data
- → A new high-severity risk
- → A change in the direction of profitability or cash flow
For signed-in investors
Sign in
The full analysis on one page
When signed in, you can see sources, risks, changes, currency calculations, and your own holdings and transactions.
Explore more
Four relevant companies
British American Tobacco p.l.c.
BTI · NYSE
A complementary comparison peer.
British American Tobacco p.l.c.-osakeanalyysi →Medical Properties Trust, Inc.
MPT · XNYS
A complementary comparison peer.
Medical Properties Trust, Inc.-osakeanalyysi →Meta Platforms, Inc.
META · NASDAQ
A complementary comparison peer.
Meta Platforms, Inc.-osakeanalyysi →